Rock Point Advisors’s AbbVie ABBV Stock Holding History

Rock Point Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Hold	1,106	–	–	0.07%	100
2026 Q1	$241K	Sell	1,106 -20	-2%	-$4.44K	0.07%	104
2025 Q4	$257K	Buy	1,126 +6	+0.5%	+$1.37K	0.06%	105
2025 Q3	$259K	Buy	1,120 +20	+2%	+$4.07K	0.07%	97
2025 Q2	$204K	Hold	1,100	–	–	0.06%	105
2025 Q1	$230K	Buy	+1,100	New	+$214K	0.07%	96
2024 Q4	–	Sell	-1,433	Closed	-$283K	–	106
2024 Q3	$283K	Hold	1,433	–	–	0.08%	91
2024 Q2	$246K	Hold	1,433	–	–	0.07%	94
2024 Q1	$261K	Sell	1,433 -11	-0.8%	-$1.9K	0.08%	92
2023 Q4	$224K	Hold	1,444	–	–	0.07%	96
2023 Q3	$215K	Buy	+1,444	New	+$212K	0.07%	97
2023 Q2	–	Sell	-1,494	Closed	-$238K	–	93
2023 Q1	$238K	Hold	1,494	–	–	0.08%	87
2022 Q4	$241K	Sell	1,494 -50	-3%	-$7.67K	0.08%	90
2022 Q3	$207K	Buy	1,544 +100	+7%	+$14.3K	0.08%	90
2022 Q2	$221K	Hold	1,444	–	–	0.08%	92
2022 Q1	$234K	Buy	+1,444	New	+$210K	0.07%	93

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rock Point Advisors's ABBV Position: Q2 2026 in Review

Rock Point Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,106 shares worth $278K. The position accounts for 0.07% of the portfolio, ranked #100.

Rock Point Advisors first reported a position in ABBV in Q1 2022 and has held it in 16 quarters since. The position peaked at $283K in Q3 2024. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Rock Point Advisors held 1,106 shares of AbbVie worth $278K as of Q2 2026.
Rock Point Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.07% of Rock Point Advisors's portfolio in Q2 2026, its #100 holding.
Rock Point Advisors first reported a position in AbbVie in Q1 2022 and has held it in 16 quarters since.
Rock Point Advisors's AbbVie position peaked at $283K in Q3 2024.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rock Point Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.